Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family

[1]  Clofazimine , 2020, Reactions Weekly.

[2]  L. Scorrano,et al.  Impaired Mitochondrial ATP Production Downregulates Wnt Signaling via ER Stress Induction. , 2019, Cell reports.

[3]  Mary C. Skolfield,et al.  Temporal integration of mitochondrial stress signals by the PINK1:Parkin pathway , 2019, BMC Molecular and Cell Biology.

[4]  R. Rizzuto,et al.  Identification of an ATP-sensitive potassium channel in mitochondria , 2019, Nature.

[5]  S. Chiang,et al.  Bergapten induces G1 arrest of non‑small cell lung cancer cells, associated with the p53‑mediated cascade. , 2019, Molecular medicine reports.

[6]  K. Chandy,et al.  Antibodies and venom peptides: new modalities for ion channels , 2019, Nature Reviews Drug Discovery.

[7]  C. Hunte,et al.  Locking loop movement in the ubiquinone pocket of complex I disengages the proton pumps , 2018, Nature Communications.

[8]  A. Felipe,et al.  Kv1.3: a multifunctional channel with many pathological implications , 2018, Expert opinion on therapeutic targets.

[9]  E. Venturini,et al.  Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo. , 2017, Cancer cell.

[10]  L. Scorrano,et al.  Optic Atrophy 1 Is Epistatic to the Core MICOS Component MIC60 in Mitochondrial Cristae Shape Control , 2016, Cell reports.

[11]  L. Leanza,et al.  Physiology of intracellular potassium channels: A unifying role as mediators of counterion fluxes? , 2016, Biochimica et biophysica acta.

[12]  C. Hunte,et al.  Structure and function of mitochondrial complex I. , 2016, Biochimica et biophysica acta.

[13]  G. Finazzi,et al.  Ion Channels in Plant Bioenergetic Organelles, Chloroplasts and Mitochondria: From Molecular Identification to Function. , 2016, Molecular plant.

[14]  L. Leanza,et al.  Biophysical Characterization and Expression Analysis of Kv1.3 Potassium Channel in Primary Human Leukemic B Cells , 2015, Cellular Physiology and Biochemistry.

[15]  A. Mattarei,et al.  N-Monosubstituted Methoxy-oligo(ethylene glycol) Carbamate Ester Prodrugs of Resveratrol , 2015, Molecules.

[16]  M. Elkalaf,et al.  Lipophilic Triphenylphosphonium Cations Inhibit Mitochondrial Electron Transport Chain and Induce Mitochondrial Proton Leak , 2015, PloS one.

[17]  Wonseok Yang,et al.  Amplification of oxidative stress by a dual stimuli-responsive hybrid drug enhances cancer cell death , 2015, Nature Communications.

[18]  S. Feske,et al.  Ion channels in innate and adaptive immunity. , 2015, Annual review of immunology.

[19]  C. Domene,et al.  In silico identification of PAP-1 binding sites in the Kv1.2 potassium channel. , 2015, Molecular pharmaceutics.

[20]  M. VanNieuwenhze,et al.  Electroreductive dimerization of coumarin and coumarin analogues at carbon cathodes. , 2015, The Journal of organic chemistry.

[21]  H. Wulff,et al.  Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis--xenograft model. , 2014, Journal of autoimmunity.

[22]  Z. Varga,et al.  Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels. , 2014, Toxicon : official journal of the International Society on Toxinology.

[23]  S. Moro,et al.  Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole , 2014, British journal of haematology.

[24]  Christine Beeton,et al.  Ion channels and anti-cancer immunity , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[25]  J. Gribben,et al.  The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies. , 2014, Seminars in cancer biology.

[26]  T. Mak,et al.  Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.

[27]  E. Condom,et al.  The voltage-dependent K+ channels Kv1.3 and Kv1.5 in human cancer , 2013, Front. Physiol..

[28]  A. Szewczyk,et al.  Putative Structural and Functional Coupling of the Mitochondrial BKCa Channel to the Respiratory Chain , 2013, PloS one.

[29]  M. Sanguinetti,et al.  Side pockets provide the basis for a new mechanism of Kv channel–specific inhibition , 2013, Nature Chemical Biology.

[30]  A. Wojtovich,et al.  Physiological consequences of complex II inhibition for aging, disease, and the mKATP channel. , 2013, Biochimica et biophysica acta.

[31]  M. Zoratti,et al.  Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia , 2013, Leukemia.

[32]  M. Zoratti,et al.  Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels. , 2012, Current medicinal chemistry.

[33]  Jianzhuang Chen,et al.  An amphiphilic pillar[5]arene: synthesis, controllable self-assembly in water, and application in calcein release and TNT adsorption. , 2012, Journal of the American Chemical Society.

[34]  K. Chandy,et al.  Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells , 2012, EMBO molecular medicine.

[35]  H. Steel,et al.  Clofazimine: current status and future prospects. , 2012, The Journal of antimicrobial chemotherapy.

[36]  K. Chandy,et al.  Therapeutic potential of peptide toxins that target ion channels. , 2011, Inflammation & allergy drug targets.

[37]  H. Wulff,et al.  Identification of phase-I metabolites and chronic toxicity study of the Kv1.3 blocker PAP-1 (5-(4-phenoxybutoxy)psoralen) in the rat , 2011, Xenobiotica; the fate of foreign compounds in biological systems.

[38]  So Yeong Lee,et al.  Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. , 2011, European journal of pharmacology.

[39]  H. Wulff,et al.  Potassium Channel Block by a Tripartite Complex of Two Cationophilic Ligands and a Potassium Ion , 2010, Molecular Pharmacology.

[40]  K. Chandy,et al.  The functional network of ion channels in T lymphocytes , 2009, Immunological reviews.

[41]  H. Wulff,et al.  4-Phenoxybutoxy-substituted heterocycles--a structure-activity relationship study of blockers of the lymphocyte potassium channel Kv1.3. , 2009, European journal of medicinal chemistry.

[42]  F. Lang,et al.  Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes , 2008, Proceedings of the National Academy of Sciences.

[43]  S. Griffey,et al.  Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis. , 2007, The Journal of investigative dermatology.

[44]  L. Scorrano,et al.  Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts , 2007, Nature Protocols.

[45]  S. Griffey,et al.  Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases , 2006, Proceedings of the National Academy of Sciences.

[46]  B. Rudy,et al.  International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels , 2005, Pharmacological Reviews.

[47]  Heike Wulff,et al.  International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels , 2005, Pharmacological Reviews.

[48]  H. Wulff,et al.  Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases , 2005, Molecular Pharmacology.

[49]  E. Campbell,et al.  Crystal Structure of a Mammalian Voltage-Dependent Shaker Family K+ Channel , 2005, Science.

[50]  E. Newell,et al.  Functional Up-regulation of HERG K+ Channels in Neoplastic Hematopoietic Cells* , 2002, The Journal of Biological Chemistry.

[51]  F. Lang,et al.  Inhibitory effects of oxidants on n-type K+ channels in T lymphocytes and Xenopus oocytes , 1997, Pflügers Archiv.

[52]  M. Lazdunski,et al.  Susceptibility of cloned K+ channels to reactive oxygen species. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Zoratti,et al.  The mitochondrial permeability transition. , 1995, Biochimica et biophysica acta.

[54]  C. Nathan,et al.  Production of large amounts of hydrogen peroxide by human tumor cells. , 1991, Cancer research.

[55]  S. Chiang,et al.  Bergapten induces G 1 arrest of non ‐ small cell lung cancer cells , associated with the p 53 ‐ mediated cascade , 2019 .